Influenza and Pneumococcal Immunization

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee

Nadira Husein MD, FRCPC Vincent Woo MD, FRCPC

  • Key Messages
  • Recommendations
  • Figures
  • Highlights
  • Full Text
  • References

Key Messages

  • Influenza immunization can reduce hospitalization rates by approximately 40% for those individuals deemed to be at high risk.
  • Pneumococcal immunization is desired in people with diabetes as they are considered as likely to be infected as those with other chronic diseases.
  • For those who are >65 years of age, a 1-time revaccination is recommended if the original vaccine was administered when they were <65 years of age with at least 5 years between administrations.

Highlights of Revisions

  • A new recommendation offers more specific details about the timing of pneumococcal immunization.


  1. 1.People with diabetes should receive an annual influenza immunization to reduce the risk of complications associated with influenza [Grade D, Consensus].
  2. 2.Pneumococcal immunization should be offered to people with diabetes. A single dose is recommended for those >18 years of age. A 1-time revaccination is recommended for those >65 years of age (if the original vaccine was given when they were <65 years of age) with at least 5 years between administrations [Grade D, Consensus].


Reproduced with permission from Canadian Journal of Diabetes © 2013 Canadian Diabetes Association. To cite this article, please refer to For citation.

*The Canadian Diabetes Association is the registered owner of the name Diabetes Canada. All content on, CPG Apps and in our online store remains exactly the same. For questions, contact